Medicamen Biotech Limited announced that at its board meeting held on May 25, 2022, recommended a final dividend at 10% on equity shares of INR 10 each that is INR 1 per equity share for the financial Year 2021-22.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
530.4 INR | +0.94% | +5.23% | -11.95% |
1st Jan change | Capi. | |
---|---|---|
-11.95% | 80.03M | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.33% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- MEDICAMEQ Stock
- News Medicamen Biotech Limited
- Medicamen Biotech Limited Recommends Final Dividend for the Financial Year 2021-22